Φορτώνει......
Botulinum toxin type A alleviates neuropathic pain and suppresses inflammatory cytokines release from microglia by targeting TLR2/MyD88 and SNAP23
BACKGROUND: Botulinum toxin type A (BTX-A) was considered to be a new potential drug for neuropathic pain (NP) treatment. RESULTS: In vivo, BTX-A attenuated chronic compression injury (CCI)-induced pain in rats, and reduced production of pro-inflammatory factors. The inhibition of BTX-A to expressio...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cell Biosci |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7724852/ https://ncbi.nlm.nih.gov/pubmed/33298171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13578-020-00501-4 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|